Antiviral Drugs Market Current Trends, Opportunities and Growth Challenges by 2030
Global Antiviral Drugs Industry Outlook The global antiviral drugs market size is expected to reach USD 50.02 Billion in 2030 and register a revenue CAGR of 3.4% during the forecast period, according to latest report by Reports and Data. Increasing number of patients infected by influenza and other viral respiratory infections, especially during the COVID-19 pandemic, is driving market revenue growth. Many factors are contributing to this rapid spread of viral infectious diseases, including increasing human mobility, rise in trade and tourism, and shifting geographic distribution of disease vectors. Human travel and migration, in particular, is a major driving force behind the global spread of viral infections. Changing environmental conditions, due to abrupt climate change, is also contributing to widespread viral infections, and this is resulting in development of novel antiviral medications, which is supporting market revenue growth. However, high costs of Research & Development (R&D) in the area of drug development is limiting market revenue growth. Furthermore, rising healthcare costs and preventive measures against viral infections are also expected to hinder revenue growth of the market during the forecast period. In-depth Study of the Competitive Landscape: The global Antiviral Drugs market consists of various market players, which make this business sphere highly competitive. In this section of the report, the authors have provided authentic information on product portfolios, new product innovations, technological capabilities, and product pricing strategies of each of these players. Moreover, it discusses the key strategies implemented by these players, such as mergers & acquisitions, joint ventures, collaborations, partnerships and agreements, to build on their market presence. Top companies profiled in the report include: GlaxoSmithKline plc., Gilead Sciences, Inc., Merck & Co., Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Pfizer Inc., and Dr. Reddy’s Laboratories Ltd. Key Market Regions Covered in the Report: North America (U.S., Canada) Europe (U.K., Italy, Germany, France, Rest of EU) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA) Drug Type Outlook (Revenue, USD Billion; 2019-2030) Generic Drugs Branded Drugs Application Outlook (Revenue, USD Billion; 2019-2030) Influenza Hepatitis A, B & C Human Immunodeficiency Virus (HIV) Herpes Respiratory Syncytial Virus (RSV) Human Coronaviruses (HCoV) Others Frequently asked questions addressed in the report: What is the revenue growth rate of the global Antiviral Drugs market over the forecast period? What are the major factors driving the growth of the Global Antiviral Drugs Market? What are the key challenges impacting the global Antiviral Drugs market growth? What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report? Request a Sample Report on Antiviral Drugs Market @ https://www.reportsanddata.com/sample-enquiry-form/1734 Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs. Get More Published Reports by Reports and Data: Retinal Prosthesis Market Positron Emission Tomography Market Platelet Aggregation Devices Market Orthopedics Instruments Market Microplate Readers Market About Reports and Data Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.